Aknefug en es it fr

Aknefug Brand names, Aknefug Analogs

Aknefug Brand Names Mixture

  • No information avaliable

Aknefug Chemical_Formula


Aknefug RX_link


Aknefug fda sheet

Aknefug FDA

Aknefug msds (material safety sheet)

Aknefug MSDS

Aknefug Synthesis Reference

Matsui et al.; J.Vitaminol.; 4; 190, 192(1958)

Aknefug Molecular Weight

300.435 g/mol

Aknefug Melting Point

181 oC

Aknefug H2O Solubility

<0.1 g/100 mL

Aknefug State


Aknefug LogP


Aknefug Dosage Forms

Capsule; Cream; Gel; Liquid

Aknefug Indication

For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.

Aknefug Pharmacology

Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).

Aknefug Absorption

1-31% (topical);

Aknefug side effects and Toxicity

No information avaliable

Aknefug Patient Information

No information avaliable

Aknefug Organisms Affected

Humans and other mammals